Ratings OptimizeRx Corporation

Equities

OPRX

US68401U2042

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
11.29 ^USD	-1.74%		-7.08%	-21.10%

Jun. 05	Transcript : OptimizeRx Corporation - Shareholder/Analyst Call
May. 14	Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024

Strengths

The prospective high growth for the next fiscal years is among the main assets of the company
Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Internet Services

	1st Jan change	Capi.	ESG Refinitiv
OPTIMIZERX CORPORATION	-21.10%	210M	C+
TENCENT HOLDINGS LIMITED	+29.97%	451B	B
NETFLIX, INC.	+33.20%	280B	D+
UBER TECHNOLOGIES, INC.	+11.91%	138B	A-
AIRBNB, INC.	+7.98%	92.55B	C-
PROSUS N.V.	+26.70%	91.02B	B+
SPOTIFY TECHNOLOGY S.A.	+70.03%	64.41B	B-
DOORDASH, INC.	+15.32%	45.22B	C+
NASPERS LIMITED	+25.04%	35.71B	C+
COSTAR GROUP, INC.	-11.83%	31.89B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes